MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Alloy Therapeutics
Parents
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
*Industry: Massachusetts
Venture Capital: Series C
Children
2021: The drug discovery company uses its ATX-Gx in vivo human antibody discovery platform, currently employed by more than 70 life sciences teams in biopharma and academia, and its setup to “democratize” research by making access easier and cheaper.
2021: The series C was led by 8VC, Presight Capital, Peter Thiel, Mubadala Capital, an unnamed sovereign wealth fund, Founders Fund, Gaingels, Luma Bio-IT, Alexandria Venture Investments and Ulysses Diversified Holdings.
Boston, Massachusetts
Errik Anderson, CEO and founder of Alloy Therapeutics (2021)
Founded 2020